Katie Kelley(127) LegalView Log in to become a member of Katie Kelley's Fan Club!
According to a recent issue of Uro Today, a publication for urologists, investigators from the Division of Nephrology at the Vanderbilt University Medical Center have been reinvestigating the link between gadolinium and other contrast dyes used in MRI/MRA procedures to the development of a rare and debilitating condition known as nephrogenic systemic fibrosis.
The scientists and medical professionals are working to better assess how gadolinium causes NSF and to whom it affects.
According to the group of investigators, contrast dyes, such as gadolinium, should be "judiciously" administered and each patient receiving the dye should probably have an evaluation to avoid the development of NSF.
According to the article, developing nephrogenic systemic fibrosis (NSF) may largely depend upon "the degree of renal dysfunction, dose of contrast agents". NSF is a new condition that develops among kidney disease patients who receive contrast dyes, such as gadolinium, for magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA).
Details of Nephrogenic Systemic Fibrosis
Nehprogenic Systemic Fibrosis is a condition that is relatively new to the medical community and develops among a small and rare population of individuals who receive gadolinium dyes during MRI/MRA procedures, however, the individuals who develop NSF also suffer from kidney disease or kidney failure.
Continued or chronic kidney disease is a condition that affects the kidney's ability to properly remove wastes within the body. The National Kidney Foundation has noted that the kidney disease can become fatal if a patient is misdiagnosed or suffers any of the following complications:
* high blood pressure
* anemia (low blood count)
* weak bones
* nerve damage
* poor nutritional health.
Kidney disease is the main common thread among patients who are diagnosed with NSF of patients who have also received contrast dyes during MRI/MRA procedures. If NSF advances, it can become extremely painful and debilitating, often effecting an individuals joints, causing no mobility on their own. Common NSF signs and symptoms include the following, according to a study from the American Journal of Roentgenology:
* edema or swelling
* athralgia
* myalgia
* extremity weakness
* persistent skin fibrosis
* woody induration of skin
* skin tightness
* skin thickening
* stiffness in both lower and upper extremities
Treating NSF
Unfortunately, there are no current treatments for NSF that can adequately cure all signs and symptoms of the painful condition. Unfortunately, because of the rareness of NSF, there are no current treatments although scientists and medical professionals continue to research potential treatments. However, it is important that an individual who has suffered from NSF contact an experienced medical attorney to better understand the legalities surrounding diagnosis of this disease. Because the disease is the cause of potential medical error it may be possible for an NSF victim to develop a gadolinium or nephrogenic systemic fibrosis lawsuit to earn monetary compensation for the painful and immobilizing disease.
It is advisable to contact an experienced NSF lawyer who can offer insight as to the link between the illness and gadolinium contrast dyes. A legal consultation is often free of charge and will offer insightful details as to the steps in creating an NSF litigation.
Copyright (c) 2008 Katie Kelley
--------
For more information on the dangers of Ketek consumption, visit http://www.ketek-legal-help.com or http://www.LegalView.com/. Here, individuals can locate the latest on legal topics ranging from new mesothelioma treatments to obtaining a medical malpractice attorney.
Disclaimer: All information on this site is provided for informational purposes only! By no means is any
information presented herein intended to substitute for the advice provided to you by any health care or other professional
or organization.
